Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kevin Persson"'
Autor:
Magnus Åstrand, Miguel R. Abboud, Videlis Nduba, Jessie Githanga, Adlette Inati, Baba Psalm Duniva Inusa, Philip Maes, Bernhards Ogutu, Kevin Persson, Elena Cela, Glenn Carlson, Maurizio Miano, Anders Berggren, Mohammad Niazi
Publikováno v:
Pediatric Blood and Cancer
Inhibition of platelet activation may reduce vaso-occlusion rates in patients with sickle cell disease (SCD). In the HESTIA4 (NCT03492931) study, 21 children with SCD received a single oral dose of the antiplatelet agent ticagrelor (0.1 mg/kg = 6 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a2ff3a25611280a53dc82f43eb6dfc
https://doi.org/10.1002/pbc.28977
https://doi.org/10.1002/pbc.28977
Autor:
Miguel R. Abboud, Magnus Åstrand, Anders Berggren, Philip Maes, Baba Inusa, Glenn Carlson, Jessie Githanga, Videlis Nduba, Adlette Inati, Mohammad Niazi, Maurizio Miano, Kevin Persson, Elena Cela
Publikováno v:
Blood. 134:1005-1005
Background: There is a significant unmet need for treatments to reduce vaso-occlusive crises (VOCs) in sickle cell disease (SCD). Until recently, the only pharmacological treatment approved for reduction of VOCs was hydroxyurea (hydroxycarbamide), an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afb6fb2dbda286d6b971ed3b8b961d42
https://doi.org/10.1182/blood-2019-129855
https://doi.org/10.1182/blood-2019-129855